Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Additions introduce a current operating-status notice and a version upgrade (v3.2.0); deletions remove the previous version tag (v3.1.0). The page now communicates potential delays due to funding and points to official sources for updates.
    Difference
    2%
    Check dated 2025-10-06T08:56:20.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T07:34:46.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:30:18.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has updated the citation for the ENHANCE-2 study, changing the publication date and revision number.
    Difference
    0.3%
    Check dated 2025-09-07T20:12:54.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information and publications related to acute myeloid leukemia. Some previous entries have been removed, including certain location details and drug information.
    Difference
    10%
    Check dated 2025-08-31T12:34:47.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.3%
    Check dated 2025-08-24T08:17:41.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.